Efficiency of platelet-rich plasma therapy in knee osteoarthritis does not depend on level of cartilage damage

por Burchard, Rene, Huflage, Hanno, Soost, Christian, Richter, Oliver, Bouillon, Bertil, Graw, Jan Adriaan
Publicado 2019

A Novel PBPK Modeling Approach to Assess Cytochrome P450 Mediated Drug‐Drug Interaction Potential of the Cytotoxic Prodrug Evofosfamide

por Lüpfert, Christian, Dyroff, Martin, von Richter, Oliver, Gallemann, Dieter, El Bawab, Samer, Dolgos, Hugues, Jung, Don, Hecht, Stefan, Johne, Andreas
Publicado 2018

GP2015, a proposed etanercept biosimilar: Pharmacokinetic similarity to its reference product and comparison of its autoinjector device with prefilled syringes

por von Richter, Oliver, Skerjanec, Andrej, Afonso, Miguel, Sanguino Heinrich, Sabine, Poetzl, Johann, Woehling, Heike, Velinova, Maria, Koch, Annelize, Kollins, Dmitrij, Macke, Lars, Wuerth, Guido
Publicado 2016

Long-term Efficacy, Safety, and Immunogenicity of the Infliximab (IFX) Biosimilar, PF-06438179/GP1111, in Patients with Rheumatoid Arthritis After Switching from Reference IFX or C...

por Cohen, Stanley B., Radominski, Sebastiao C., Kameda, Hideto, Kivitz, Alan J., Tee, Michael, Cronenberger, Carol, Zhang, Min, Hackley, Sarah, Rehman, Muhammad I., von Richter, Oliver, Alten, Rieke
Publicado 2020

Randomised, double-blind, phase III study comparing the infliximab biosimilar, PF-06438179/GP1111, with reference infliximab: efficacy, safety and immunogenicity from week 30 to we...

por Alten, Rieke, Batko, Bogdan, Hala, Tomas, Kameda, Hideto, Radominski, Sebastiao C, Tseluyko, Vira, Babic, Goran, Cronenberger, Carol, Hackley, Sarah, Rehman, Muhammad, von Richter, Oliver, Zhang, Min, Cohen, Stanley
Publicado 2019